Tobias Tritschler: Evaluating Timing, Translation and Preparedness in COVID-19 Anticoagulation Management
Tobias Tritschler, Leitender Arzt at Insel Gruppe, shared a post on LinkedIn about a recent article he and his collogues co-authored, published in JACC, adding:
“A long journey has come to an end.
This article brings together what we set out to do, but it also captures the challenges and precious lessons we learned along the way.
Our IPDMA shows that therapeutic-dose anticoagulation reduced the risk of organ support or death in noncritically ill patients hospitalized for COVID-19. More broadly, it illustrates how earlier coordination, data sharing, and evidence synthesis could have accelerated the translation of evidence into clinical practice during a public health emergency.
A heartfelt thank you to all investigators for your support, trust, patience, and commitment throughout this journey.
It was a privilege to work with you all.”
Title: Timing, Translation, and Preparedness: Lessons Learned From COVID-19 Anticoagulation in Noncritically Ill Hospitalized Patients
Authors: Tobias Tritschler, Valentin Fuster, Patrick R. Lawler, Michael E. Farkouh, Caterina E. Marx, Matthew D. Neal, Michelle Sholzberg, Alex C. Spyropoulos, Steven Y.C. Tong, Nuria Muñoz-Rivas, Marc Blondon, Jeffrey S. Berger, Behnood Bikdeli, Marco Cattaneo, Mary Cushman, Mark Goldin, Ewan C. Goligher, Judith S. Hochman, Peter Jüni, Zoe K. McQuilten, Nuccia Morici, Parham Sadeghipour, Balasubramanian Venkatesh, Stéphane Zuily, Alain Amstutz, Drahomir Aujesky, Marc Carrier, Robin V. Hofstetter, Srinivas Murthy, Marc Rodger, Leslie Skeith, Areti A. Veroniki, Brian Hutton, Ryan Zarychanski, Gregg W. Stone, and Grégoire Le Gal
Stay updated with Hemostasis Today.
-
Oct 28, 2026, 08:40Simon Fletcher: The Hidden Burden of Non-Severe Haemophilia
-
Oct 28, 2026, 08:08Paul Agwu: A Low Platelet Count Is Not a Diagnosis – It Is a Clue
-
Oct 28, 2026, 07:54Ifeanyichukwu Ifechidere: When Normal Results Don’t Explain the Bleeding
-
Oct 28, 2026, 06:06Thirunavukkarasu Angappan: Anti-TFPI Antibodies and an Antithrombin-Lowering Drug
-
Oct 28, 2026, 05:52Reegan Burnell-Clarke: Pegcetacoplan and the Evolving Treatment Landscape of PNH
-
Oct 28, 2026, 03:50ZhiChao (David) Yang: MedicalBench Tests AI in Clinical Reasoning
-
Oct 28, 2026, 03:46Phillip Smith: Strengthening Partnerships and Connections in the Rare Disease and Hemophilia Communities
-
Oct 28, 2026, 03:42Ashley Bradley: Understanding Jalen Hurts’ Diagnosis: DVT and Venous Thromboembolism in Athletes
-
Oct 28, 2026, 03:39Gregory Denomme: Petz and Garratty’s Immune Hemolytic Anemias Third Edition